Roche Holding



Ebitda Lave om Dato
AbbVie USD 6.92B 258M 2024-12
Alcon AG USD 514M 133M 2024-12
Almirall EUR 84.69M 66.19M 2024-06
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Fresenius EUR 972M 150M 2024-12
Fresenius Medical Care EUR 554.32M 256.68M 2024-12
Galapagos EUR -48446000 52.4M 2024-09
Genmab DKK 2.23B 85M 2024-09
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
GRIFOLS EUR 536.1M 85.37M 2024-12
Hikma Pharmaceutical USD 453M 98M 2024-06
Lonza CHF 873M 107M 2024-06
Merck EUR 1.62B 114M 2024-09
Merck USD 7.12B 1.06B 2024-12
Novartis USD 5.19B 319M 2024-12
Orion EUR 147M 80.5M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Philips EUR 945M 594M 2024-12
Recordati EUR 216.96M 25.45M 2024-09
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
UCB EUR 652M 105M 2024-06



Roche Holding - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.